ZDF
Sign inSign up

Vulnerabilities

Vulnerability · CVE-2026-107631

The Record of Consent Extension for Complianz plugin for WordPress is vulnerable to Stored Cross-Site Scripting via the 'uid' parameter in all versions up to, and incl…

Published Oct 14, 2026 · catalog updated Oct 15, 2026 · the affected product

Check if you run it

No confirmed exploitation is on record for CVE-2026-107631. EPSS is 0.32%. Act only if a listed version of the affected product is installed.

Gaps on this record

  • No plain product name is stored. The page cannot tell you which product to check.
  • No vendor fix or required action is stored. Compare the linked advisory before you change production.
Severity
High7.2
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
0.32%
Remediation
Version ranges on file
Affected products
stated named in the record

The Record of Consent Extension for Complianz plugin for WordPress is vulnerable to Stored Cross-Site Scripting via the 'uid' parameter in all versions up to, and including, 2.5 due to insufficient input sanitization and output escaping. This makes it possible for unauthenticated attackers to inject arbitrary web scripts in pages that will execute whenever a user accesses an injected page. This is possible because the enforcing nonce is emitted via wp_localize_script on wp_enqueue_scripts and is therefore readable by any unauthenticated frontend visitor, and no capability or role check gates the write path.

Are you affected?

Enter the version you run. The result uses only the ranges stored on this record.

The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.

  • stated named in the record<= 2.5

How to fix CVE-2026-107631

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

No confirmed exploitation is on record for CVE-2026-107631. EPSS is 0.32%. Act only if a listed version of the affected product is installed.

Which versions are affected?

Compare what you have installed with named in the record <= 2.5. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

CWE-79: Cross-site Scripting (XSS). EPSS 0.32%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Technology hubs

WordPress security

Code

The project this record applies to. Exploit listings stay in References.

Timeline

Detection, updates, and resolution for this record.

  1. Oct 14, 2026 · NIST NVD

    Detected

    The Record of Consent Extension for Complianz plugin for WordPress is vulnerable to Stored Cross-Site Scripting via the 'uid' parameter in all versions up to, and including, 2.5 due to insufficient input sanitization and output escaping. This makes it possible for unauthenticated attackers to inject arbitrary web scripts in pages that will execute whenever a user accesses an injected page. This is

  2. Oct 15, 2026 · NIST NVD

    Updated

    The Record of Consent Extension for Complianz plugin for WordPress is vulnerable to Stored Cross-Site Scripting via the 'uid' parameter in all versions up to, and including, 2.5 due to insufficient input sanitization and output escaping. This makes it possible for unauthenticated attackers to inject arbitrary web scripts in pages that will execute whenever a user accesses an injected page. This is

Sources

  • CVE.orgVulnerability recordCVE-2026-107631

    Official CVE identifier

    cve.org
  • FIRST EPSSExploitation probabilityCVE-2026-107631

    30-day exploitation probability 0.3%

    first.org
  • NIST NVDVulnerability recordCVE-2026-107631

    The Record of Consent Extension for Complianz plugin for WordPress is vulnerable to Stored Cross-Site Scripting via the 'uid' parameter in all versions up to, and including, 2.5 due to insufficient input sanitization and output escaping. This makes it possible for unauthenticated

    nvd.nist.gov

References

Freshness

Last verified in this catalog Oct 18, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.